Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-135

I was critical of this company management. You made many of my post disappear. No complaints at all! All good!
I'll outright reject CR in token of sheer disrespect and dsilikes and ... to the MM et al. looting SHs' and Tax payers' money.
To my thought, it was intentional plot to delay everyhting for another CR. Everytime R&D incentives were received. MM's copy paste comments "these R&D incentives will be used for commercialisations". No commercialisation, nothing.... What joke! What a easy way of absorbing money!

Govt should investigate if they (MM et al.) enage CROs of their acquantances to overvoice or channel money through back door. CR is for them to run their families and for their bread and butter, There is no commercialisations or partnership or ...

They do not care for a realistic timeline becasue they know that the longer these trials and analyses will contine, the more time they will get to suck money before they get unemployed. SHs are 20% responsible not becoming cautious of this company and Govt are 80% responsible for not enforcing oversight and regulatory actions on the announcements made by this company. Govt should not let this company do any CR.

NO more CR for MM's bread and butter! Enough time given! Let them find funding by selling whatever they have or having Gilead have 45% stake on biotron.